台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    150.0
  • 漲跌
    ▼1.0
  • 漲幅
    -0.66%
  • 成交量
    11
  • 產業
    上櫃 生技醫療類股
  • 68人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-凱基-基隆 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-基隆 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/0700.005151.20151.00-59-54.55%
2023/02/0600.001161.50162.00-166-1.51%
2023/01/101156.5000.00154.001681.46%
2023/01/0900.001162.50162.00-167-1.47%
2022/11/181144.0000.00143.501751.33%
2022/08/3100.001175.00175.00-195-1.05%
2022/02/0800.006130.50130.00-663-9.42%
2022/01/051113.5000.00113.501293.34%
2021/09/0100.00191.0091.00-144-2.25%
2021/08/27189.7000.0090.001432.32%
2021/06/112104.5000.00106.002385.14%
2021/03/1900.002116.00116.00-253-3.76%
2021/03/0200.001111.50111.00-151-1.94%
2021/01/131110.0000.00108.501362.72%
2021/01/082105.0000.00104.502336.02%
2020/04/17497.1000.0096.404924.31%
2020/03/091120.001121.00116.500700.00%
2019/10/1700.001126.50126.50-188-1.13%
2019/10/1500.001124.50126.00-192-1.08%
2019/05/0600.001125.50126.50-166-1.51%
2019/03/191119.0000.00118.501442.23%
2019/03/1100.003124.83123.50-339-7.66%
2019/03/073117.0000.00114.003348.65%
2018/05/174145.7500.00146.0043491.15%
2018/05/1000.002153.00157.00-2357-0.56%
2018/04/2600.003157.83156.50-3366-0.82%
2018/04/251165.5000.00166.0013710.27%
2018/04/234179.501175.00172.0033640.82%
2018/04/201173.0000.00173.0013420.29%
2018/04/0900.001169.00168.00-1322-0.31%
2018/04/033170.006165.75167.50-3315-0.95%
2018/04/027159.573158.50160.5042971.35%
2018/03/312156.003154.17153.50-1288-0.35%
2018/03/304151.633154.50151.0012820.35%
2018/03/293147.003148.50147.5002700.00%
2018/03/273143.506142.00141.00-3262-1.14%
2018/03/264140.501142.50142.5032641.14%
2018/03/2200.001143.50139.00-1267-0.37%
2018/03/191140.501139.50139.5002690.00%
2018/03/151138.5000.00144.5012780.36%
2018/01/3000.002180.00177.00-2324-0.62%
2018/01/2900.001184.00183.00-1325-0.31%
2018/01/261182.0000.00179.5013210.31%
2018/01/192177.501177.00174.0013100.32%
2018/01/171165.5000.00165.5012930.34%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章